AC Immune
Christopher Roberts has over 20 years of experience in the media and technology industries. Christopher is currently the Interim Chief Financial Officer at AC Immune. Prior to joining AC Immune, Roberts served as the Vice President of Sales at Transform, Inc., where they were responsible for leading a team of sales professionals and driving revenue growth. Roberts also served as the Senior Vice President of Sales for OnDemand Everywhere at Comscore, Inc., where they oversaw the company's sales operations and drove Comscore's expansion into new markets.
After completing their GED, Christopher Roberts attended Mt. Hood Community College where they studied business and music.
Their manager is Andrea Pfeifer, CEO. They work with Johannes Streffer - Chief Medical Officer, Julien Rongère - VP, Regulatory Affairs & Quality Assurance, and Piergiorgio Donati - Chief Technical Operations Officer.
This person is not in any offices
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.